Immune Activation and CD8+ T-Cell Differentiation towards Senescence in HIV-1 Infection
Open accessThe DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Abstract
Progress in the fight against the HIV/AIDS epidemic is hindered by our failure to elucidate the precise reasons for the onset of immunodeficiency in HIV-1 infection. Increasing evidence suggests that elevated immune activation is associated with poor outcome in HIV-1 pathogenesis. However, the basis of this association remains unclear. Through ex vivo analysis of virus-specific CD8(+) T-cells and the use of an in vitro model of naïve CD8(+) T-cell priming, we show that the activation level and the differentiation state of T-cells are closely related. Acute HIV-1 infection induces massive activation of CD8(+) T-cells, affecting many cell populations, not only those specific for HIV-1, which results in further differentiation of these cells. HIV disease progression correlates with increased proportions of highly differentiated CD8(+) T-cells, which exhibit characteristics of replicative senescence and probably indicate a decline in T-cell competence of the infected person. The differentiation of CD8(+) and CD4(+) T-cells towards a state of replicative senescence is a natural process. It can be driven by excessive levels of immune stimulation. This may be part of the mechanism through which HIV-1-mediated immune activation exhausts the capacity of the immune system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Terminally differentiated (CD28−CD57+) T lymphocytes are characterized by strong effector functions such as expression of cytotoxins (e.g., Perforin and Granzyme B) and cytolytic capacity, and a marked inflammatory profile by way of increase proinflammatory cytokine (e.g., IFN-γ, TNF-α, MIP-1β) secretion [86].”
From Aging of the immune system: Focus on inflammation and vaccination (2016) · cites this paper as [86]
Experimental — accuracy not yet measuredIn the citing paper
“The increased proportion of terminally differentiated oligoclonal effector memory T-cell populations in the elderly has been shown to be the consequence of recurrent or chronic immune activation [86].”
From Aging of the immune system: Focus on inflammation and vaccination (2016) · cites this paper as [86]
In the citing paper
“However, terminally differentiated T cells are constrained by limited proliferative capabilities in tandem with short telomeres, and to a large extent, have been defined as approaching senescence [86, 87].”
From Aging of the immune system: Focus on inflammation and vaccination (2016) · cites this paper as [86]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phenotypic Analysis of Antigen-Specific T Lymphocytes
Altman, J. D., Moss, P. A. H., Goulder, P. J. R., Barouch, D. H., McHeyzer-Williams, M. G., Bell, J. I., McMichael, A. J., & Davis, M. M. (1996) · Science · doi:10.1126/science.274.5284.94 · Cited by 3,544 · cited 1×
“HLA–peptide tetrameric complexes (‘‘tetramers’’) were produced as previously described (Altman et al. 1996) and included the following specificity: A2 HIV p17-SLYNTVATL and pol-ILKEPVHGV, A2 CMV pp65-NLVPMVATV, A2 EBV BMLF1-GLCTLVAML, A2 influenza matrix-GILGFVFTL, A2 melanA-ELAGIGILTV, B7 HIV nef-TPGPGVRYPL and gp41-…”
MethodSelf-citationKoup, R. A., Safrit, J. T., Cao, Y., Andrews, C. A., McLeod, G., Borkowsky, W., Farthing, C., & Ho, D. D. (1994) · Journal of Virology · doi:10.1128/jvi.68.7.4650-4655.1994 · Cited by 2,495 · cited 1×
“During primary human immunodeficiency virus 1 (HIV-1) infection, the immune system appears to respond appropriately in order to prevent viral spread, with the mounting of a strong HIV-specific CD8þ T-cell response and a corresponding reduction in viraemia (Koup et al. 1994).”
BackgroundCounting Antigen-Specific CD8 T Cells: A Reevaluation of Bystander Activation during Viral Infection
Murali-Krishna, K., Altman, J. D., Suresh, M., Sourdive, D. J. D., Zajac, A. J., Miller, J. D., Slansky, J., & Ahmed, R. (1998) · Immunity · doi:10.1016/s1074-7613(00)80470-7 · Cited by 1,943 · cited 1×
“T-cell compartment. Our data indicate that HIV-1 infection results in immune activation not only directly, but also indirectly, with the activation of cells specific for non-HIV antigens. In recent years, the role of potential bystander activation has been reevaluated and is now considered less important (”
BackgroundChanges in thymic function with age and during the treatment of HIV infection
Douek, D. C., McFarland, R. D., Keiser, P. H., Gage, E. A., Massey, J. M., Haynes, B. F., Polis, M. A., Haase, A. T., Feinberg, M. B., Sullivan#, J. L., et al. (1998) · Nature · doi:10.1038/25374 · Cited by 1,893 · cited 1×
“2002c), HIV-infected individuals are characterised by decreased thymic output (Douek et al. 1998) and reduced naı̈ve T-cell numbers (Roederer et al.”
BackgroundLineage relationship and protective immunity of memory CD8 T cell subsets
Wherry, E. J., Teichgräber, V., Becker, T. C., Masopust, D., Kaech, S. M., Antia, R., von Andrian, U. H., & Ahmed, R. (2003) · Nature Immunology · doi:10.1038/ni889 · Cited by 1,864 · cited 1×
“’’ Protective immunity has recently been associated with the proliferative capacity of virus-specific CD8 T-cells in the mouse model (Wherry et al. 2003).”
BackgroundMemory CD8+ T cells vary in differentiation phenotype in different persistent virus infections
Appay, V., Dunbar, P. R., Callan, M., Klenerman, P., Gillespie, G. M. A., Papagno, L., Ogg, G. S., King, A., Lechner, F., Spina, C. A., et al. (2002) · Nature Medicine · doi:10.1038/nm0402-379 · Cited by 1,571 · cited 13×
“One could speculate that the association between different stages of CD8þ T-cell differentiation and viral specificity of these cells, as previously described (Appay et al. 2002a; Tussey et al. 2003), may be related to the stimulation intensity received by the cells from priming onwards.”
BackgroundMethodInfluentialSelf-citationPhenotypic and functional separation of memory and effector human CD8+ T cells
Hamann, D., Baars, P. A., Rep, M. H. G., Hooibrink, B., Kerkhof-Garde, S. R., Klein, M. R., & Lier, R. A. W. V. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.9.1407 · Cited by 1,366 · cited 1×
“The assumption that CD28 /CD27 T-cells are protective effector cells is mainly based on the fact that these cells possess strong cytotoxic potential, expressing high levels of perforin, as seen ex vivo (Hamann et al. 1997).”
BackgroundBorrow, P., Lewicki, H., Wei, X., Horwitz, M. S., Peffer, N., Meyers, H., Nelson, J. A., Gairin, J. E., Hahn, B. H., Oldstone, M. B. A., et al. (1997) · Nature Medicine · doi:10.1038/nm0297-205 · Cited by 1,183 · cited 1×
“Continuous adaptive mutation (Borrow et al. 1997) and destruction or impairment of elements necessary for an optimal immune response (e.”
BackgroundBrenchley, J. M., Karandikar, N. J., Betts, M. R., Ambrozak, D. R., Hill, B. J., Crotty, L. E., Casazza, J. P., Kuruppu, J., Migueles, S. A., Connors, M., et al. (2003) · Blood · doi:10.1182/blood-2002-07-2103 · Cited by 1,073 · cited 4×
“…following priming of T-cells in vitro (see Figure 2C), although this remained relatively modest (below 10%), possibly due to the high susceptibility to activation induced cells death of CD57þ Tcells (Brenchley et al. 2003; unpublished data) in the interleukin-2 (IL-2)-supplemented assay conditions.”
BackgroundInfluentialMigueles, S. A., Laborico, A. C., Shupert, W. L., Sabbaghian, M. S., Rabin, R., Hallahan, C. W., Baarle, D. V., Kostense, S., Miedema, F., McLaughlin, M., et al. (2002) · Nature Immunology · doi:10.1038/ni845 · Cited by 1,005 · cited 1×
“This is supported by Migueles et al. (2002), who showed that HIV-1-infected long-term nonprogressors are characterised by HIV-1-specific CD8þ T-cells that maintain a strong proliferative capacity following in vitro stimulation (cells defined mainly as CD45ROþ/CD28þ/CD27þ early-differentiated cells).”
Background
Research works printed but not linked: 3
- Gerna, 1998, New Microbiol, 21, 293
- Giorgi, 1993, J Acquir Immune Defic Syndr, 6, 904
- Hellerstein, 2003, J Clin Invest, 112, 956, 10.1172/JCI200317533 · doi:10.1172/jci200317533 · Paper page
Cited by
Items 401–476 of 476
The role of HLA-C restricted CD8+T cell responses in the control of HIV replication.
Mkhwanazi, N. P. (2010) · ResearchSpace (University of KwaZulu-Natal)
Seeking a mechanism of action for the anti-HIV properties of the CD8 antiviral factor, CAF
Shridhar, V. (2011) · D-Scholarship@Pitt (University of Pittsburgh)
Immune maturation in early childhood and the influence of herpesvirus infections
Sohlberg, E. (2013) · DiVA (Stockholm University) · Cited by 1
The Role of Non-Classical Regulatory T Cells in HIV-1 Infection
Li, C. (2013) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
Ghiglione, Y. (2015) · Repositorio Digital Institucional de la Universidad de Buenos Aires (Universidad de Buenos Aires)
Characterisation of llama antibody fragments able to act as HIV-1 entry inhibitors
Quigley, A. F. (2009) · OpenGrey (Institut de l'Information Scientifique et Technique) · Cited by 1
Avaliação do perfil imune de aves empregando citometria de fluxo
Beirão, B. C. B. (2011) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Chéret, A. (2014) · theses.fr (ABES) · doi:10.70675/476201c0z519az47dfz9e6az9e7e63dc4e55 · Cited by 2
Viro-immunology of EBV-HIV co-infection
Piriou, E. (2005) · UvA-DARE (University of Amsterdam)
Poonam, P. (2009) · D-Scholarship@Pitt (University of Pittsburgh)
Pillay, S. T. (2010) · SUNScholar (Stellenbosch University)
HMBG-1 and other soluble factors in HIV-1 pathogenesis
Barqasho, B. (2009) · Figshare
Rodriguez, L., Rodríguez, J. W., Font, G., Cubano, L. A., Boukli, N. M., Otero, M. A., HUNTER, R. F., Nair, M. P. N., & Ríos‐Olivares, E. (2007) · American Journal of Infectious Diseases · doi:10.3844/ajidsp.2007.208.216
HIV and the Sharpen Edge Between Protective and Pathogenic Immune Responses to the CD4 Self Antigen
Breda, D., Mollica, L., Luison, E., & Burastero, S. E. (2010)
Osuna-Gutierrez, C. E. (2012) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
Characterization of HIV specific T cell responses during acute and early HIV-1 subtype C infection
Mlotshwa, M. (2014) · University of the Witwatersrand, Johannesburg Institutional Repository on DSpace (University of the Witwatersrand, Johannesburg)
Managing the HIV Epidemic in the Developing World – Progress and Challenges
van der Ryst, E., Palmer, M. J., & van Vuuren, C. (2011) · Royal Society of Chemistry eBooks · doi:10.1039/9781849733496-00322
Falutz, J. (2016) · Springer eBooks · doi:10.1007/978-3-319-20131-3_2 · Cited by 1
de Meireles, C. A. B. (2016) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Elevated Apoptosis of CD8+ T Lymphocytes during HIV-1 Infection
Zaunders, J., Estaquier, J., & Corbeil, J. (2005) · CRC Press eBooks · doi:10.1201/9781420038156.ch14
Speiser, D. E., Romero, P. J., Leyvraz, S., Rufer, N., Guillaume, P., Krieg, A. Μ., Coupland, S. E., Rimoldi, D., Jandus, C., & Voelter, V. (2015)
Self-citationSanyal, A. (2016) · D-Scholarship@Pitt (University of Pittsburgh)
Mechanisms Underlying Immunomodulation of HIV-1-Specific T-cell Responses
Herasimtschuk, A. (2012) · Spiral (Imperial College London) · doi:10.25560/10565
Invecchiamento cellulare e infezione da HIV
Dentone, C., & Fenoglio, D. (2016) · JHA - Journal of HIV and Ageing · doi:10.19198/jha31418
“Inoltre in questa popolazione cellulare si riscontra un aumento dei subsets CD57+ considerate come lo stadio finale delle cellule T senescenti (15).”
BackgroundPanditrao, M. V. (2012) · eScholarship (California Digital Library)
HIV, Immune activation and Endothelial Damage in Malawian Adults
Kelly, C. (2017) · University of Liverpool · doi:10.17638/03006512 · Cited by 1
Mudd, J. C. (2014) · OhioLink ETD Center (Ohio Library and Information Network)
Pulmonary hypertension in people living with HIV/AIDS
Singh, S. (2019) · Journal of Indian College of Cardiology · doi:10.4103/jicc.jicc_6_19
IMMUNOLOGICAL ENTEROPATHY IN AN ACCELERATED MACAQUE MODEL OF AIDS
Croteau, J. D. (2016)
Acevedo-Sáenz, L., Perdomo-Celis, F., Montoya, C. J., & Velilla, P. A. (2019) · Current HIV Research · doi:10.2174/1570162x17666191017105910
Basta, D., & Latinovic, O. S. (2020) · Journal of Clinical and Laboratory Medicine · doi:10.16966/2572-9578.135
“In addition to high levels of viral antigen, the strong pro-inflammatory immune activation and compromised T-cell homeostasis during HIV-1 infection contribute to the development of T-cell exhaustion [17].”
BackgroundSystemic lymphocyte trafficking markers in TB and TB/HIV co-infections.
Pillay, K. (2019) · ResearchSpace (University of KwaZulu-Natal)
Mathematical modeling of immune responses to Viral pathogens
Wahogo, C. (2021)
HEFFICON: HIV Effectiveness Italian Conference.
Antinori, A., Andreoni, M., Perno, C. F., & Lazzarin, A. (2015) · PubMed
Enhancing T-cell responses to vaccination of HIV-1 infected subjects on antiretroviral therapy
Ramirez, L. (2014) · ScholarlyCommons (University of Pennsylvania)
(2014) · ASM Press eBooks · doi:10.1128/9781555815653.refs
HIV Infection as a Model of Accelerated Immunosenescence
Appay, V., Sauce, D., & Kelleher, A. D. (2018) · Springer eBooks · doi:10.1007/978-3-319-64597-1_50-1 · Cited by 3
Self-citationPahwa, S. G., & Phenix, B. N. (2005) · CRC Press eBooks · doi:10.1201/9781420038156.ch11
HIV-Associated Immune Exhaustion
Appay, V., Lissina, A., & Sauce, D. (2018) · Springer eBooks · doi:10.1007/978-1-4939-7101-5_186
Self-citationHartigan-O’Connor, D. J., & Brander, C. (2021) · Oxford University Press eBooks · doi:10.1093/med/9780197576595.003.0006
Immunopathogenesis of HIV-1 Infection
Aldrovandi, G. M., & Tobin, N. H. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-75608-2.00110-5
Qi, H., Li, Q., Li, Y., Jin, F., Kang, Z., Hou, J., & Wang, Y. (2022) · Journal of Immunological Methods · doi:10.1016/j.jim.2022.113404
Pitavastatin in the Prevention of Cardiovascular Disease in People Living with HIV: A Review
Whiteson, H. Z., Drogy, M., Eickel, G., & Frishman, W. H. (2024) · Cardiology in Review · doi:10.1097/crd.0000000000000646 · Cited by 1
“21 While there are numerous pathophysiological mechanisms that contribute to the elevated inflammation observed in PLWH, we will briefly shift our focus to monocytes & macrophages as their elevation in HIV is a known atherogenic risk factor.”
Castro, R. C., Gravina, H. D., Sugiyama, F. H. C., Lamarre, Y., Fontanari, C., Powell, B. H., Gololobova, O. A., Liao, Z., Almeida, F. B. D. R., Haddad, S. K., et al. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.5035905
Hartigan-O’Connor, D. J., & Brander, C. (2025) · Oxford University Press eBooks · doi:10.1093/med/9780197812631.003.0005
CD38 expression on CD8+ T cells as a marker of immune activation and ART efficacy in HIV
Keşre, G., Oğuzman, H., Çabalak, M., & Özcan, O. (2025) · Journal of Investigative Medicine · doi:10.1177/10815589251393916
“40,41 Short-term ART significantly improved CD8+ T cell percentage ( p = 0.031) but not the absolute count ( p = 0.943).”
InfluentialMonitoring Antigen-Specific Responses in Clinical Trials of Cancer Immunotherapy
Chapuis, A. G., & Yee, C. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4732-0_14
CD8+ CD57+ T cells in tumor immunology
Sada-Ovalle, M. I. (2008) · Springer eBooks · doi:10.1007/978-1-4020-6931-4_5 · Cited by 1
A mouse model for the pathogenesis of immunodeficiency virus infection
Marques, R. (2009) · OpenGrey (Institut de l'Information Scientifique et Technique)
Fernandes, J. R., Pinto, T. N. C., Arruda, L. B., da Silva, C. C. B. M., de Carvalho, C. R. F., Pinto, R. M. C., da Silva Duarte, A. J., & Benard, G. (2022) · Figshare · doi:10.6084/m9.figshare.19181452
Lara‐Aguilar, V., Llamas-Adán, M., Brochado‐Kith, O., Crespo‐Bermejo, C., Grande‐García, S., Arca-Lafuente, S., de los Santos, I., PRADO, C. M. C. O., Alía, M., Sainz-Pinós, C., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26787448
Fernandes, J. R., Pinto, T. N. C., Arruda, L. B., da Silva, C. C. B. M., de Carvalho, C. R. F., Pinto, R. M. C., da Silva Duarte, A. J., & Benard, G. (2022) · Figshare · doi:10.6084/m9.figshare.19181449
Awakening intracellular immunity for functional HIV curePreprint
Lanna, A., Rinaldi, F., & Stingone, C. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.04.697570
Fortier, Y. (2019) · theses.fr (ABES) · doi:10.70675/51a7553dzb5caz4997zb48az68f16ad0ee5f
Évaluation de la sénescence endothéliale et leucocytaire dans le choc septique
Merdji, H. (2021) · theses.fr (ABES) · doi:10.70675/cbfec802z6c0dz4e06z9276zd4a44c11c814
Efficacité et évolution de la réponse lymphocytaire T CD8 au cours de l'infection par VIH-1
White, E. (2022) · theses.fr (ABES) · doi:10.70675/46537244ze125z43e1z9c39z92cf9f645f78
Inflammation, aging and chronic diseases : implication of inflammasomes
Guerville, F. (2023) · theses.fr (ABES) · doi:10.70675/eac3286czda71z4606z9c90z3d3efeaf1afe
Mercier‐Letondal, P. (2025) · theses.fr (ABES) · doi:10.70675/fb692847z0188z4b0czaf29za1e4d337e717
邵姗, Guo, X., Zhang, M., Dong, X., Wang, X., Bao, S., & Xu, Y. (2026) · European journal of medical research · doi:10.1186/s40001-026-04738-6
Zhang, Y., Yong, Y., Liu, W., Hu, D., Ji, C., & Ma, C. (2026) · Virology Journal · doi:10.1186/s12985-026-03243-w
“One possible key factor contributing to this phenomenon is T cell exhaustion (TEX), which may hinder the body from mounting an effective virus-specific immune response and limit the control of viral latency and reactivation [3, 4].”
Flores-Piñas, M., Chafino, S., Viladés, C., Domingo, P., Villar, B., Prieto, P., Inciarte, A., Mallolas, J., Blanco, J., Negredo, E., et al. (2026) · Molecular Medicine · doi:10.1186/s10020-026-01575-5
“This limited molecular signature in CD8 ⁺ T cells may also relate to the use of pre-ART samples, as CD8 ⁺ -driven immune perturbations typically intensify during ART-mediated immune activation (Papagno 2004; Takata 2023).”
Corrêa-Castro, G., Silva-Freitas, M. L., de Paula, L., Dutra, M. R. T., Pereira, L. S., Araujo, I. L., Galvani, R. G. A., Bonomo, A. C., Savino, W., Gomes-Silva, A., et al. (2026) · Microbial Pathogenesis · doi:10.1016/j.micpath.2026.108737
Immunosenescence and immune dysfunction in treated and untreated HIV-infected individuals
Unissa, A. N., Madheswaran, A., Inbanathan, A., Malathi, M., Vasantha, M., Kannan, M., Mangayarkarasi, S., Senthilnathan, R., Elamathi, V., Pradeep, A., et al. (2026) · The Indian Journal of Medical Research · doi:10.25259/ijmr_1597_2025
HIV‐1 Vpr Drives a B Cell‐Like Phenotype in Primary CD4 + T Cells
Wang, P. G., Li, J., Wang, W., Meng, Z., Wu, H., Du, S., Deng, K., & Cai, J. (2026) · MedComm · doi:10.1002/mco2.71018
Garza‐Martinez, L., Apadeer, M., Aquino, N. M., Turano, P. S., Akbulut, E., Oswald, D., Singh, S., & Fitzgerald-Bocarsly, P. A. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1985303
Gumbi, P. P. (2010) · Open University of Cape Town (University of Cape Town)
Virus Specific T-Cell Responses
Appay, V. (2005) · Springer eBooks · doi:10.1007/1-4020-3623-x_4
“Such model is supported by longitudinal ex vivo analysis of virus specific CD8+ T-cells in human viral infections ( Figure 1 ) (38, 43) , as well as telomere length (see later) measurement in the different subsets and in vitro data following naïve T-cell priming (70) .”
InfluentialSelf-citation
Metadata
- Authors
- Papagno, L., Spina, C. A., Marchant, A., Salio, M., Rufer, N., Little, S., Dong, T., Chesney, G., Waters, A., Easterbrook, P., Dunbar, P. R., Shepherd, D., Cerundolo, V., Emery, V., Griffiths, P., Conlon, C., McMichael, A. J., Richman, D. D., Rowland-Jones, S. L., & Appay, V.
- Affiliations
- University of Milan (IT)
- University of California San Diego (US)
- John Radcliffe Hospital (GB)
- The Royal Free Hospital (GB)
- ORCID
- Venue
- PLoS Biology
- Publisher
- Public Library of Science (PLoS)
- Published
- 2004-02-17
- Volume
- 2
- Issue
- 2
- Pages
- e20
- ISSN
- 1544-9173 (ISSN-L)
- 1545-7885
- PMC
- PMC340937
- OpenAlex
- W1965845165
- Cited by
- 478
- References
- 71
- Citations by year
- 2026: 10 · 2025: 10 · 2024: 14 · 2023: 10 · 2022: 20 · 2021: 18 · 2020: 13 · 2019: 20 · 2018: 22 · 2017: 21 · 2016: 29 · 2015: 23 · 2014: 22 · 2013: 28 · 2012: 31
- FWCI
- 3.53
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Biology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- IRIS (submittedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- UCL Discovery (University College London) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion, other-oa)
- Funders
- Wellcome Trust
- Cancer Research UK
- King's College London
- European Commission (QLK2-CT)
- National Institutes of Health
- Center for AIDS Research, University of Washington
- University of California, San Diego
- Medical Research Council
- National Institute of Allergy and Infectious Diseases (AI-29164, R24AI106039, R37AI029164)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Infectious Diseases › HIV-related health complications and treatments
- Keywords
- HIV-1 infection, immune activation, CD8+ T cell differentiation, replicative senescence, T cell exhaustion, acute HIV-1 infection, disease progression, CD4+ T cells, virus-specific T cells, T cell priming, immunodeficiency
- MeSH terms
- Aging, Cell Differentiation, Humans, Lymphocyte Activation, CD4-Positive T-Lymphocytes, HIV Infections, CD8-Positive T-Lymphocytes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.